Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap6.31B
Enterprise Value5.33B
P/E Ratio17.12
PEG Ratio-0.6
Price/Sales Ratio4.28
Price/Book Ratio0.95
Enterprise/Revenue3.53
Enterprise/EBITDA11.34

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.25
Operating Margin0.29
AD

Management Effectiveness

Return On Assets0.05
Return On Equity0.06

Income Statement

Revenue1.15B
Revenue/Share0.99
Gross Profit930.62M
EBITDA357.17M
Net Income278.58M
Diluted EPS0.27

Balance Sheet

Total Cash1.09B
Total Cash/Share1.04
Total Debt4.73M
Total Debt/Equity0
Current Ratio11.09
Book Value Per Share4.47

Price History

52-Week Change-28.86
52-Week High7.03
52-Week Low4.09
Moving Average 50 Days5.47
Moving Average 200 Days6.04

Statistics

Average Volume12.29M
Shares Outstanding1.05B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.13
Trailing Annual Dividend Yield3.07
Payout Ratio0.52
Last Split Factor13:10
Last Split DateMay 10, 2017
AD